Market revenue in 2023 | USD 552.6 million |
Market revenue in 2030 | USD 670.1 million |
Growth rate | 2.8% (CAGR from 2023 to 2030) |
Largest segment | Quantitative |
Fastest growing segment | Digital |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quantitative, Digital, End-point |
Key market players worldwide | Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to real time pcr, digital pcr, and end point pcr market will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 85.23% in 2023. Horizon Databook has segmented the China real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
In 2023, China held a substantial share of the Asia Pacific market. Growth in the market can be attributed to the presence of local manufacturers and the increasing export of new PCR kits. For instance, in September 2022, QuantuMDx collaborated with Sansure Biotech to commercialize Q-POC and its assay in China.
China, one of the world’s largest chemical producers, expedited the development of testing kits. China plays a crucial role in sending supplies for testing to other countries. Over 100 companies in China are selling kits to European countries.
Companies in the country are constantly involved in product development. For instance, in December 2020, The company is also aiming to commercialize its NGS-based cancer diagnostic technologies. These innovations are expected to drive the market over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the China real time pcr, digital pcr, and end point pcr market , including forecasts for subscribers. This country databook contains high-level insights into China real time pcr, digital pcr, and end point pcr market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account